Javascript must be enabled to continue!
Osteoporosis in rheumatic diseases
View through CrossRef
The article presents a review of studies that have examined osteoporosis in rheumatic diseases, including rheumatoid arthritis, spondylarthritis, psoriatic arthritis, systemic connective tissue diseases, and systemic vasculitis. The review discusses the pathogenesis, diagnosis and treatment of osteoporosis in these diseases, presents the results of epidemiological studies assessing the risk factors and the prevalence of osteoporosis in rheumatic diseases. There was a high prevalence of osteoporosis and fractures in rheumatic diseases, exceeding the population, associated primarily with systemic and local inflammation, as well as with the intake of glucocorticoids. It is indicated that the existing strategies for the treatment of rheumatic diseases may partially reduce bone loss, but long-term administration of glucocorticoids, on the contrary, increase bone resorption. The review presents data on the medications for the treatment of osteoporosis and approaches to the treatment of glucocorticoid osteoporosis.
Title: Osteoporosis in rheumatic diseases
Description:
The article presents a review of studies that have examined osteoporosis in rheumatic diseases, including rheumatoid arthritis, spondylarthritis, psoriatic arthritis, systemic connective tissue diseases, and systemic vasculitis.
The review discusses the pathogenesis, diagnosis and treatment of osteoporosis in these diseases, presents the results of epidemiological studies assessing the risk factors and the prevalence of osteoporosis in rheumatic diseases.
There was a high prevalence of osteoporosis and fractures in rheumatic diseases, exceeding the population, associated primarily with systemic and local inflammation, as well as with the intake of glucocorticoids.
It is indicated that the existing strategies for the treatment of rheumatic diseases may partially reduce bone loss, but long-term administration of glucocorticoids, on the contrary, increase bone resorption.
The review presents data on the medications for the treatment of osteoporosis and approaches to the treatment of glucocorticoid osteoporosis.
Related Results
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Osteoporosis is a bone disease characterized by decreased bone density. The incidence of osteoporosis increases with age, especially age ≥ 50 years. Research from the International...
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
In osteoporosis (OP) disease, the strength of bones is decreased, and it is mostly correlated with the loss of bone tissues and destruction of bone micro structure, making the pati...
Evaluation of Osteoporosis Frequency in Patients With Recurrent Kidney Stones
Evaluation of Osteoporosis Frequency in Patients With Recurrent Kidney Stones
Osteoporosis is defined as a reduction in bone density up to 2.5 standard deviations less than the maximum mean bone density in humans. It is estimated that 50% to 80% of the diffe...
A pooled analysis of the association between sarcopenia and osteoporosis
A pooled analysis of the association between sarcopenia and osteoporosis
Background:
Sarcopenia is a progressive generalized skeletal muscle disorder that causes the accelerated loss of muscle mass and function. Osteoporosis is a systemic co...
P05 Osteoporosis in thalassemia; a case with multifactorial aetiology
P05 Osteoporosis in thalassemia; a case with multifactorial aetiology
Abstract
Introduction
Thalassemia patients are prone to osteoporosis due to multifactorial reasons, including anaemia, bone marr...
Serum Biochemical Factors as Indicators of Osteoporosis: A Cross-Sectional Study
Serum Biochemical Factors as Indicators of Osteoporosis: A Cross-Sectional Study
Introduction:
Osteoporosis is a bone condition that disrupts bone structure, reduces its strength, and increases the risk of fractures. While osteoporosis is
commonly recognized as...
Studying Risk Factors Association with Osteoporosis in Post Kidney Transplantation Patients
Studying Risk Factors Association with Osteoporosis in Post Kidney Transplantation Patients
Osteoporosis that associate with kidney transplantation is an important cause of morbidity to the patients that warranted extensive study about possible causes of osteoporosis i...
FAKTOR-FAKTOR YANG MEMPENGARUHI MOTIVASI PENCEGAHAN OSTEOPOROSIS
FAKTOR-FAKTOR YANG MEMPENGARUHI MOTIVASI PENCEGAHAN OSTEOPOROSIS
Background: Osteoporosis is characterized by a decrease in bone mass density and deterioration of bone microarchitecture, so that the bones become brittle and break easily. Efforts...

